ESSA Pharma to Participate in Three Upcoming Investor Conferences

Rhea-AI Summary

ESSA Pharma Inc. (NASDAQ: EPIX) announced participation in three virtual investor conferences on November 8, 2021. David R. Parkinson, President and CEO, along with COO Peter Virsik and CFO David S. Wood, will host one-on-one meetings. The events include the Jefferies London Healthcare Conference on November 18, Piper Sandler 33rd Annual Healthcare Conference on November 22, and Evercore ISI HealthCONx Conference on December 2. Webcasts will be available on ESSA's website for 90 days post-event.

VANCOUVER, Canada and HOUSTON, Texas, Nov. 8, 2021 /PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that David R. Parkinson, President and Chief Executive Officer of ESSA Pharma, will participate in and host one-on-one meetings at three upcoming virtual investor conferences. Peter Virsik, ESSA's Chief Operating Officer, and David S. Wood, ESSA's Chief Financial Officer, will also be participating in the one-on-one meetings.

Presentation Details

Event: Jefferies London Healthcare Conference
Format (on-demand): Fireside Chat
Date: Thursday, November 18, 2021
Time: 8:00 a.m. GMT / 3:00 a.m. ET

Event: Piper Sandler 33^rd Annual Healthcare Conference
Format (on-demand): Fireside Chat
Date: Monday, November 22, 2021
Time: 10 a.m. ET

Event: Evercore ISI 4^th Annual HealthCONx Virtual Conference 
Format (on-demand): Fireside Chat
Date: Thursday, December 2, 2021
Time: 1:50 p.m. ET

Webcasts of the events can be accessed in the Investors/Events & Presentations section of ESSA's website at www.essapharma.com. Following the events, the webcasts will be archived on the ESSA website for 90 days.

About ESSA Pharma Inc.
ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. For more information, please visit www.essapharma.com and follow us on Twitter under @ESSAPharma.

View original content:https://www.prnewswire.com/news-releases/essa-pharma-to-participate-in-three-upcoming-investor-conferences-301418273.html

SOURCE ESSA Pharma Inc

FAQ

What investor conferences will ESSA Pharma participate in November 2021?

ESSA Pharma will participate in the Jefferies London Healthcare Conference on November 18, the Piper Sandler 33rd Annual Healthcare Conference on November 22, and the Evercore ISI HealthCONx Conference on December 2, 2021.

Who will represent ESSA Pharma at the upcoming conferences?

David R. Parkinson, President and CEO, Peter Virsik, COO, and David S. Wood, CFO will represent ESSA Pharma at the upcoming conferences.

When is the Jefferies London Healthcare Conference?

The Jefferies London Healthcare Conference is scheduled for November 18, 2021, at 8:00 a.m. GMT.

How can I access the webcasts from ESSA Pharma's conferences?

The webcasts can be accessed on the Investors/Events & Presentations section of ESSA Pharma's website and will be archived for 90 days following the events.

What is the focus of ESSA Pharma's research?

ESSA Pharma is focused on developing novel therapies for the treatment of prostate cancer.